Navigation Links
More Clinical Data Required to Support European Approval of Desvenlafaxine as a Potential Treatment for Vasomotor Symptoms
Date:3/12/2008

MADISON, N.J., March 12 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that it would need to conduct additional clinical studies to address questions from the Committee for Medicinal Products for Human Use (CHMP) regarding the risk-benefit profile of desvenlafaxine as a treatment for vasomotor symptoms. As a result, Wyeth voluntarily withdrew its application for European Marketing Authorisation for desvenlafaxine for the treatment of vasomotor symptoms (hot flashes) associated with menopause.

"We believe that desvenlafaxine can provide women with a non-hormonal option to treat vasomotor symptoms (VMS), and Wyeth remains committed to developing the molecule for this indication," says Gary L. Stiles, M.D., Executive Vice President and Chief Medical Officer, Wyeth Pharmaceuticals. "Some of the questions raised by the CHMP can be addressed with our planned clinical trials, including the 12-month study Wyeth is initiating with post- menopausal women early this year. The Company also is considering whether to conduct additional studies."

About Wyeth Pharmaceuticals

Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women's health care, infectious disease, gastrointestinal health, central nervous system, inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include W
'/>"/>

SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
2. Genetic research unveils common origins for distinct clinical diagnoses
3. Derma Sciences Announces Numerous Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming SAWC Conference
4. Akela Pharma initiates its first abuse deterrent opioid Phase I clinical trial
5. Sensor necklace aims to increase elderly and clinical trial participant drug compliance
6. Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance
7. Affinium Pharmaceuticals, Ltd. Announces Initiation of a Phase I Clinical Trial for AFN-1252, its Novel Anti-staphylococcal Antibiotic
8. Crdentia Appoints Randall Turnbull to Senior Vice President and Chief Clinical Officer
9. Clinical depression raises risk of death for heart attack patients years after attack
10. IAVI and VaxDesign partner to develop a clinical trial in a test tube for AIDS vaccines
11. Skin Friendly Releases Clinically Proven Hypoallergenic Anti-Bacterial Barrier Lotion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
...pened in the Marie Curie Cancer Care hospice in Be...ngoing redevelopment.// The unit has made provisi... open out onto a courtyard area. In addition the ...a family member to stay overnight with the patient...
...Ph.D. and Helain Landy, M.D. of Georgetown Univers...ious methods of family //planning while they are i...ontemporary Obstetrics & Gynecology journal which ...ng the training period and its implications. Physi...
...f developing atopic dermatitis in babies at high r...ead of print in the Archives// of Disease in Child...cs (oligosaccharides), which promote the growth of...ifidobacteria that boost the development of a heal...
...ry was successfully performed on an eight-month-ol....// Ebtisam Ibrahim was initially evaluated by a ...ine Hospital and was diagnosed to have complete at...ng pressures -- a condition wherein there are hole...
Other Medicine News:Health News:Gap Exists between Medical School Teaching and Physician’s Practic 2
(Date:9/4/2008)...d orphan designation for the treatment of Acute My...INCETON, N.J., Sept. 4 /- Celator Pha...Drug Administration (FDA) has granted orphan,drug ...iposome Injection,for the treatment of Acute Myelo...g to conduct two randomized Phase 2,studies with C...
(Date:9/4/2008)...etin for Obstetrician-Gynecologists States UFE Mee...inimally Invasive Interventional,Radiology Treatme...e,Fibroids, FAIRFAX, Va., Sept. 4 /PRNewswire-USN...y, a national organization of nearly 4,500 doctors...ated to improving health,care through minimally in...
(Date:9/4/2008)...ed Survival Data for Ipilimumab to be Presented, ... Medarex, Inc.,(Nasdaq: MEDX ) announced today th...stigational anti-CTLA-4 antibody, in melanoma are ...e 33rd Congress of the European Society,for Medica... in Stockholm.,Many of the following abstracts wil...
(Date:9/3/2008)...alia, Sept. 4 /Xinhua--,Pha...XSL) today announced,that it has enrolled the firs... trial evaluating Bronchitol in cystic fibrosis su... 41 hospitals across North,America, Argentina and ...rmaxis seeks approval to market Bronchitol for cys...
Breaking Medicine Technology:Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 3Sleep Deprivation Helps Spot Sleepwalkers 14898 1Sleep Deprivation Helps Spot Sleepwalkers 14898 2Commissions Revenue Cap Proposal Would Require Cuts in Education Health and Safety and Harm Business Climate 14895 1Commissions Revenue Cap Proposal Would Require Cuts in Education Health and Safety and Harm Business Climate 14895 2Family Discussion Plays Role in Breast Cancer Awareness 14892 1Family Discussion Plays Role in Breast Cancer Awareness 14892 2Teams From Carnegie Mellon Yale Manitoba Win Tepper Schools 2008 McGinnis Venture Competition 14890 1Teams From Carnegie Mellon Yale Manitoba Win Tepper Schools 2008 McGinnis Venture Competition 14890 2
... 2007 - Ceragenix Pharmaceuticals,Inc. (OTCBB:CGX...ous disease and dermatology, today announced that ...strated virtually no biofilm,formation in a 21 day...ted with Ceragenins,were soaked daily in a phospha...ter. At day 21, the catheters were challenged with...
...nic for Human TNFa, LAUSANNE, Switzerland, March 1...rm), a global independent biopharmaceutical,develo... medical,conditions, announces the presentation of...f action of Debio-0512 as an anti-TNFa,therapeutic...animal,models of acute and chronic inflammation. D...
Other Medicine Technology:Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 2Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 3Preclinical Update - Debio-0512 Therapeutic Vaccine for the,Treatment of Chronic and Acute Inflammatory Conditions 2
The pedicle screw insertion assembly incorporates slotted guides for easy rod insertion and construct locking. The PathFinder MIS System uses an ingenious technique in which the pedicle screw inserti
Kerrison (Spurling) Laminectomy Rongeur. 15 cm - 6, thick footplate, large handle, 90 up-cutting, 2 mm wide.
Micro-Kerrison Laminectomie Rongeur and Stella Punch, golden springs, with ejector. 18 cm - 7 1/8, very delicate, narrow footplate, small handle, 40 up-cutting, jaws 2 mm wide.
...osterior Impacted Instrument Set offers maximum di...the advantages offered by the Tangent Posterior Im...tion and the ability to reproduce the technique. S... proper vertebral body distraction. A variety of s...
Medicine Products: